Atlas Trials

TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect Study

Clinical trial NCT01308606 · COMPLETED

Trial details

NCT number
NCT01308606
Sponsor
Tibotec Pharmaceuticals, Ireland
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C
Start date
2011-03-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.